Sign in
4

Changes in Ownership

ACTUATE THERAPEUTICS, INC. Filed Acc 0001104659-24-090619

Director sold 18,750 shares at $8.00 ($150,000)

  • Director acquired 28,464 shares (option exercise)
  • Director acquired 2,577,312 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

THOMSON TODD S · Director

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-14 Conversion : show line 1 in the form +1,058,318 1,105,636 I
2024-08-14 Conversion : show line 2 in the form +726,163 726,163 I
2024-08-14 Conversion : show line 3 in the form +69,445 1,175,081 I
2024-08-14 Conversion : show line 4 in the form +146,870 873,033 I
2024-08-14 Conversion : show line 5 in the form +138,889 138,889 I
2024-08-14 Conversion : show line 6 in the form +230,597 230,597 I
2024-08-14 Conversion : show line 7 in the form +132,908 271,797 I
2024-08-14 Conversion : show line 8 in the form +24,138 254,735 I
Open-market sales · 18,750 sh · avg $8.00 · $150,000

Table II: Derivative

11 lines
Date Transaction Shares Owned after D/I
2024-08-14 Conversion : show line 12 in the form Series B-1 Redeemable Convertible Preferred Stock +1,058,318 0 I
2024-08-14 Conversion : show line 13 in the form Series B-2 Redeemable Convertible Preferred Stock +726,163 0 I
2024-08-14 Conversion : show line 14 in the form Series B-3 Redeemable Convertible Preferred Stock +69,445 0 I
2024-08-14 Conversion : show line 15 in the form Series B-3 Redeemable Convertible Preferred Stock +146,870 0 I
2024-08-14 Conversion : show line 16 in the form Series B-3 Redeemable Convertible Preferred Stock +138,889 0 I
2024-08-14 Conversion : show line 17 in the form Series B-4 Redeemable Convertible Preferred Stock +230,597 0 I
2024-08-14 Conversion : show line 18 in the form Series B-4 Redeemable Convertible Preferred Stock +132,908 0 I
2024-08-14 Conversion : show line 19 in the form Series C Redeemable Convertible Preferred Stock +24,138 0 I
Loading xslF345X05/tm2421960-1_4seq1.xml…